{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T22:31:54Z","timestamp":1698013914526},"reference-count":16,"publisher":"BMJ","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart"],"published-print":{"date-parts":[[1990,9,1]]},"DOI":"10.1136\/hrt.64.3.186","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T21:46:00Z","timestamp":1190151960000},"page":"186-189","source":"Crossref","is-referenced-by-count":5,"title":["Ischaemic left ventricular failure: evidence of sustained benefit after 18 months' treatment with xamoterol."],"prefix":"10.1136","volume":"64","author":[{"given":"E","family":"Vigholt-Sorensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Faergeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/hrt.58.6.572","article-title":"Mortality in heart failure: clinical variables of prognostic value","volume":"58","author":"Cleveland, J.G.F.; Dargie, H.J.; Ford, I.","year":"1987","unstructured":"Cleveland JGF, Dargie HJ, Ford I. Mortality in heart failure: clinical variables of prognostic value. Br Heart J 1987;58:572-82.","journal-title":"Br Heart J"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJM197112232852601","article-title":"The natural history of congestive heart failure","volume":"285","author":"McKee, P.A.; Castelli, W.P.; McNamara, P.; Kannel, W.B.","year":"1971","unstructured":"McKee PA, Castelli WP, McNamara P, Kannel WB. The natural history of congestive heart failure. N Engl J Med 1971;285:1441-7.","journal-title":"N Engl J Med"},{"key":"ref_3","first-page":"489","article-title":"The German and Austrian Xamoterol Study Group. Double-blind placebo-controlled comparison of digoxin and xamoterol in chronic heart failure","volume":"i:","year":"1988","unstructured":"The German and Austrian Xamoterol Study Group. Double-blind placebo-controlled comparison of digoxin and xamoterol in chronic heart failure. Lancet 1988;i: 489-93.","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/0002-9149(83)90297-7","article-title":"Effects of a cardioselective fi, partial agonist ('Corwin') on left ventricular function and myocardial metabolism in patients with previous myocardial infarction","volume":"51","author":"Rousseau, M.F.; Pouleur, H.; Vincent, M.F.","year":"1983","unstructured":"Rousseau MF, Pouleur H, Vincent MF. Effects of a cardioselective fi, partial agonist ('Corwin') on left ventricular function and myocardial metabolism in patients with previous myocardial infarction. Am J Cardiol 1983;51:1267-73.","journal-title":"Am J Cardiol"},{"issue":"587","key":"ref_5","first-page":"17","article-title":"Effect ofxamoterol","volume":"118","author":"Malajo, A.O.; Bennett, D.H.","year":"1985","unstructured":"Malajo AO, Bennett DH. Effect ofxamoterol (ICI 118 587), a new beta, adrenoceptor partial agonist, on resting haemodynamic variables-and exercise tolerance in patients with left ventricular dysfunction. Br Heart J 1985;54: 17-21.","journal-title":"(ICI; a new beta, adrenoceptor partial agonist, on resting haemodynamic variables-and exercise tolerance in patients with left ventricular dysfunction"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1476-5381.1982.tb09309.x","article-title":"The cardiovascular effects of ICI 118,587: a #-adrenoceptor partial agonist","volume":"77","author":"Nuttall, A.; Snow, H.M.","year":"1982","unstructured":"Nuttall A, Snow HM. The cardiovascular effects of ICI 118,587: a #-adrenoceptor partial agonist. Br J Pharmacol 1982;77:381-8.","journal-title":"Br J Pharmacol"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00005344-198805000-00006","article-title":"The selectivity of xamoterol, Prenalterol and Salbutamol as assessed by their effects in the presence and absence of ICI 118,551","volume":"11","author":"McCaffrey, P.M.; Riddell, J.G.; Shanks, R.G.","year":"1988","unstructured":"McCaffrey PM, Riddell JG, Shanks RG. The selectivity of xamoterol, Prenalterol and Salbutamol as assessed by their effects in the presence and absence of ICI 118,551. J Cardiovasc Pharnacol 1988;11:543-51.","journal-title":"J Cardiovasc Pharnacol"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/01.CIR.77.4.721","article-title":"Neurohormonal interactions and adaptations in congestive heart failure","volume":"77","author":"Packer, M.","year":"1988","unstructured":"Packer M. Neurohormonal interactions and adaptations in congestive heart failure. Circulation 1988;77:721-30.","journal-title":"Circulation"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/hrt.62.5.335","article-title":"adrenoceptor partial agonist, in patients with ischaemic dysfunction ofthe left ventricle","volume":"62","year":"1989","unstructured":"Vigholt-Sorensen E, Faergeman 0, Snow HM. Effects of xamoterol, a,B, adrenoceptor partial agonist, in patients with ischaemic dysfunction ofthe left ventricle. Br Heart J 1989;62:335-41.","journal-title":"Br Heart J"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJM198306163082402","article-title":"Determinants of survival in patients with ventricular tachyarrhythmias","volume":"308","author":"Swerdlow, C.D.; Winkle, R.A.; Mason, J.W.","year":"1983","unstructured":"Swerdlow CD, Winkle RA, Mason JW. Determinants of survival in patients with ventricular tachyarrhythmias. N EnglJ Med 1983;308:1436-42.","journal-title":"N EnglJ Med"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1056\/NEJM198107233050402","article-title":"Decreased lymphocyte beta-adrenergic-receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist pirbuterol","volume":"305","author":"Colucci, W.S.; Alexander, R.W.; Williams, G.H.","year":"1981","unstructured":"Colucci WS, Alexander RW, Williams GH, et al. Decreased lymphocyte beta-adrenergic-receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist pirbuterol. N Engl J Med 1981;305:185-90.","journal-title":"N Engl J Med"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/01.CIR.69.2.298","article-title":"Long-term haemodynamic effects of prenalterol in patients with severe congestive heart failure","volume":"69","author":"Lambertz, H.; Meyor, J.; Erbel, R.","year":"1984","unstructured":"Lambertz H, Meyor J, Erbel R. Long-term haemodynamic effects of prenalterol in patients with severe congestive heart failure. Circulation 1984;69:298-305.","journal-title":"Circulation"},{"key":"ref_13","first-page":"208","article-title":"Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade?","volume":"53","author":"Glover, D.R.; Wathen, C.G.; Murray, R.G.; Petch, M.C.; Muir, A.L.; Littler, W.A.","year":"1985","unstructured":"Glover DR,Wathen CG, Murray RG, Petch MC, Muir AL, Littler WA. Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade? A six month randomised double blind comparison with placebo. Br Heart J 1985;53:208-15.","journal-title":"Br Heart J; blind comparison with placebo"},{"issue":"1 16","key":"ref_14","first-page":"\"15\" # \"54","article-title":"Beneficial effects of #,-adrenoceptor stabilization and #2-adrenoceptor blockade with xamoterol in severe ischaemic heart failure treated with ace-inhibitors","volume":"11","author":"Abstract","year":"1988","unstructured":"Pouleur H, Hanet C, Gurne 0, Rousseau MF. Beneficial effects of #,-adrenoceptor stabilization and #2-adrenoceptor blockade with xamoterol in severe ischaemic heart failure treated with ace-inhibitors [Abstract]. J Am Coll Cardiol 1988;11:1 16A. 15 Heikkila J. The clinical dilemma of the patient with angina pectoris and heart failure. Practical Cardiology 1986; 12:54-66.","journal-title":"J Am Coll Cardiol; The clinical dilemma of the patient with angina pectoris and heart failure"},{"key":"ref_15","first-page":"123","article-title":"Improvement of global and regional left ventricular function in patients with previous myocardial infarction by a new f,-adrenoceptor partial agonist","volume-title":"ICI 118,587. Eur Heart","volume":"3","author":"Pouleur, H.; Rousseau, M.F.; Mengeot, P.; Veriter, C.; Vincent, M.F.; Brasseur, L.A.","year":"1982","unstructured":"Pouleur H, Rousseau MF, Mengeot P, Veriter C, Vincent MF, Brasseur LA. Improvement of global and regional left ventricular function in patients with previous myocardial infarction by a new f,-adrenoceptor partial agonist, ICI 118,587. Eur Heart J 1982;3:123-7."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/BF00615956","article-title":"Effects of xamoterol a new beta-adrenoceptor partial agonist in patients with angina pectoris","volume":"29","author":"Barrios, L.; Geboers, J.; Piessens, J.H.; de Geest, H.","year":"1986","unstructured":"Barrios L, Geboers J, Piessens JH, de Geest H. Effects of xamoterol a new beta-adrenoceptor partial agonist in patients with angina pectoris. Eur J Clin Pharmacol 1986;29:667-71.","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/hrt.64.3.186","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T01:06:46Z","timestamp":1601082406000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/hrt.64.3.186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,9,1]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1990,9,1]]}},"URL":"https:\/\/doi.org\/10.1136\/hrt.64.3.186","relation":{},"ISSN":["1355-6037"],"issn-type":[{"value":"1355-6037","type":"print"}],"subject":[],"published":{"date-parts":[[1990,9,1]]}}}